LymphedemaV1, PubMed, Checkpoint, bibRecord, 001709

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.

Identifieur interne : 001709 ( PubMed/Checkpoint ); précédent : 001708; suivant : 001710

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.

Auteurs : Ramakrishna U. Rao [États-Unis] ; Kumara C. Nagodavithana [Sri Lanka] ; Sandhya D. Samarasekera [Sri Lanka] ; Asha D. Wijegunawardana [Sri Lanka] ; Welmillage D Y. Premakumara [Sri Lanka] ; Samudrika N. Perera [Sri Lanka] ; Sunil Settinayake [Sri Lanka] ; J Phillip Miller [États-Unis] ; Gary J. Weil [États-Unis]

Source :

PLoS neglected tropical diseases [ 1935-2735 ] ; 2014.

RBID : pubmed:25393404

Descripteurs français

KwdFr :
- ADN des helminthes (isolement et purification), Adolescent, Adulte, Adulte d'âge moyen, Albendazole (usage thérapeutique), Animaux, Anticorps antihelminthe (sang), Antigènes d'helminthe (sang), Antihelminthiques (administration et posologie), Culex (parasitologie), Diéthylcarbamazine (usage thérapeutique), Enfant, Femelle, Filaricides (usage thérapeutique), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Jeune adulte, Microfilaria (immunologie), Microfilaria (isolement et purification), Mâle, Prévalence, Sri Lanka (épidémiologie), Vecteurs insectes (parasitologie), Éradication de maladie, Études longitudinales, Études transversales.
MESH :
- administration et posologie : Antihelminthiques.
- immunologie : Microfilaria.
- isolement et purification : ADN des helminthes, Microfilaria.
- parasitologie : Culex, Vecteurs insectes.
- sang : Anticorps antihelminthe, Antigènes d'helminthe.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Diéthylcarbamazine, Filaricides.
- épidémiologie : Filariose lymphatique, Sri Lanka.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Enfant, Femelle, Humains, Jeune adulte, Mâle, Prévalence, Éradication de maladie, Études longitudinales, Études transversales.

English descriptors

KwdEn :
- Adolescent, Adult, Albendazole (therapeutic use), Animals, Anthelmintics (administration & dosage), Antibodies, Helminth (blood), Antigens, Helminth (blood), Child, Cross-Sectional Studies, Culex (parasitology), DNA, Helminth (isolation & purification), Diethylcarbamazine (therapeutic use), Disease Eradication, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Female, Filaricides (therapeutic use), Humans, Insect Vectors (parasitology), Longitudinal Studies, Male, Microfilariae (immunology), Microfilariae (isolation & purification), Middle Aged, Prevalence, Sri Lanka (epidemiology), Young Adult.
MESH :
- chemical , administration & dosage : Anthelmintics.
- chemical , blood : Antibodies, Helminth, Antigens, Helminth.
- chemical , isolation & purification : DNA, Helminth.
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial, Sri Lanka.
- immunology : Microfilariae.
- isolation & purification : Microfilariae.
- parasitology : Culex, Insect Vectors.
- Adolescent, Adult, Animals, Child, Cross-Sectional Studies, Disease Eradication, Female, Humans, Longitudinal Studies, Male, Middle Aged, Prevalence, Young Adult.

Abstract

The Sri Lankan Anti-Filariasis Campaign conducted 5 rounds of mass drug administration (MDA) with diethycarbamazine plus albendazole between 2002 and 2006. We now report results of a comprehensive surveillance program that assessed the lymphatic filariasis (LF) situation in Sri Lanka 6 years after cessation of MDA.

DOI: 10.1371/journal.pntd.0003281
PubMed: 25393404

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001214
to stream PubMed, to step Curation: 001214

Links to Exploration step

pubmed:25393404

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.</title>
<author><name sortKey="Rao, Ramakrishna U" sort="Rao, Ramakrishna U" uniqKey="Rao R" first="Ramakrishna U" last="Rao">Ramakrishna U. Rao</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Nagodavithana, Kumara C" sort="Nagodavithana, Kumara C" uniqKey="Nagodavithana K" first="Kumara C" last="Nagodavithana">Kumara C. Nagodavithana</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Samarasekera, Sandhya D" sort="Samarasekera, Sandhya D" uniqKey="Samarasekera S" first="Sandhya D" last="Samarasekera">Sandhya D. Samarasekera</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wijegunawardana, Asha D" sort="Wijegunawardana, Asha D" uniqKey="Wijegunawardana A" first="Asha D" last="Wijegunawardana">Asha D. Wijegunawardana</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Premakumara, Welmillage D Y" sort="Premakumara, Welmillage D Y" uniqKey="Premakumara W" first="Welmillage D Y" last="Premakumara">Welmillage D Y. Premakumara</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perera, Samudrika N" sort="Perera, Samudrika N" uniqKey="Perera S" first="Samudrika N" last="Perera">Samudrika N. Perera</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Settinayake, Sunil" sort="Settinayake, Sunil" uniqKey="Settinayake S" first="Sunil" last="Settinayake">Sunil Settinayake</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, J Phillip" sort="Miller, J Phillip" uniqKey="Miller J" first="J Phillip" last="Miller">J Phillip Miller</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Weil, Gary J" sort="Weil, Gary J" uniqKey="Weil G" first="Gary J" last="Weil">Gary J. Weil</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25393404</idno>
<idno type="pmid">25393404</idno>
<idno type="doi">10.1371/journal.pntd.0003281</idno>
<idno type="wicri:Area/PubMed/Corpus">001214</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001214</idno>
<idno type="wicri:Area/PubMed/Curation">001214</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001214</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001214</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001214</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.</title>
<author><name sortKey="Rao, Ramakrishna U" sort="Rao, Ramakrishna U" uniqKey="Rao R" first="Ramakrishna U" last="Rao">Ramakrishna U. Rao</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Nagodavithana, Kumara C" sort="Nagodavithana, Kumara C" uniqKey="Nagodavithana K" first="Kumara C" last="Nagodavithana">Kumara C. Nagodavithana</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Samarasekera, Sandhya D" sort="Samarasekera, Sandhya D" uniqKey="Samarasekera S" first="Sandhya D" last="Samarasekera">Sandhya D. Samarasekera</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wijegunawardana, Asha D" sort="Wijegunawardana, Asha D" uniqKey="Wijegunawardana A" first="Asha D" last="Wijegunawardana">Asha D. Wijegunawardana</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Premakumara, Welmillage D Y" sort="Premakumara, Welmillage D Y" uniqKey="Premakumara W" first="Welmillage D Y" last="Premakumara">Welmillage D Y. Premakumara</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perera, Samudrika N" sort="Perera, Samudrika N" uniqKey="Perera S" first="Samudrika N" last="Perera">Samudrika N. Perera</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Settinayake, Sunil" sort="Settinayake, Sunil" uniqKey="Settinayake S" first="Sunil" last="Settinayake">Sunil Settinayake</name>
<affiliation wicri:level="1"><nlm:affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</nlm:affiliation>
<country xml:lang="fr">Sri Lanka</country>
<wicri:regionArea>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo</wicri:regionArea>
<wicri:noRegion>Colombo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, J Phillip" sort="Miller, J Phillip" uniqKey="Miller J" first="J Phillip" last="Miller">J Phillip Miller</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author><name sortKey="Weil, Gary J" sort="Weil, Gary J" uniqKey="Weil G" first="Gary J" last="Weil">Gary J. Weil</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName><region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">PLoS neglected tropical diseases</title>
<idno type="eISSN">1935-2735</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Albendazole (therapeutic use)</term>
<term>Animals</term>
<term>Anthelmintics (administration & dosage)</term>
<term>Antibodies, Helminth (blood)</term>
<term>Antigens, Helminth (blood)</term>
<term>Child</term>
<term>Cross-Sectional Studies</term>
<term>Culex (parasitology)</term>
<term>DNA, Helminth (isolation & purification)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Disease Eradication</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Female</term>
<term>Filaricides (therapeutic use)</term>
<term>Humans</term>
<term>Insect Vectors (parasitology)</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Microfilariae (immunology)</term>
<term>Microfilariae (isolation & purification)</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Sri Lanka (epidemiology)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ADN des helminthes (isolement et purification)</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Animaux</term>
<term>Anticorps antihelminthe (sang)</term>
<term>Antigènes d'helminthe (sang)</term>
<term>Antihelminthiques (administration et posologie)</term>
<term>Culex (parasitologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Enfant</term>
<term>Femelle</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Microfilaria (immunologie)</term>
<term>Microfilaria (isolement et purification)</term>
<term>Mâle</term>
<term>Prévalence</term>
<term>Sri Lanka (épidémiologie)</term>
<term>Vecteurs insectes (parasitologie)</term>
<term>Éradication de maladie</term>
<term>Études longitudinales</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anthelmintics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term>
<term>Antigens, Helminth</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>DNA, Helminth</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antihelminthiques</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Sri Lanka</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Microfilaria</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Microfilariae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Microfilariae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>ADN des helminthes</term>
<term>Microfilaria</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Culex</term>
<term>Vecteurs insectes</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Culex</term>
<term>Insect Vectors</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term>
<term>Antigènes d'helminthe</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Sri Lanka</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Animals</term>
<term>Child</term>
<term>Cross-Sectional Studies</term>
<term>Disease Eradication</term>
<term>Female</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Enfant</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Prévalence</term>
<term>Éradication de maladie</term>
<term>Études longitudinales</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Sri Lankan Anti-Filariasis Campaign conducted 5 rounds of mass drug administration (MDA) with diethycarbamazine plus albendazole between 2002 and 2006. We now report results of a comprehensive surveillance program that assessed the lymphatic filariasis (LF) situation in Sri Lanka 6 years after cessation of MDA.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25393404</PMID>
<DateCreated><Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>05</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>8</Volume>
<Issue>11</Issue>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>PLoS neglected tropical diseases</Title>
<ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.</ArticleTitle>
<Pagination><MedlinePgn>e3281</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0003281</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Sri Lankan Anti-Filariasis Campaign conducted 5 rounds of mass drug administration (MDA) with diethycarbamazine plus albendazole between 2002 and 2006. We now report results of a comprehensive surveillance program that assessed the lymphatic filariasis (LF) situation in Sri Lanka 6 years after cessation of MDA.</AbstractText>
<AbstractText Label="METHODOLOGY AND PRINCIPAL FINDINGS" NlmCategory="RESULTS">Transmission assessment surveys (TAS) were performed per WHO guidelines in primary school children in 11 evaluation units (EUs) in all 8 formerly endemic districts. All EUs easily satisfied WHO criteria for stopping MDA. Comprehensive surveillance was performed in 19 Public Health Inspector (PHI) areas (subdistrict health administrative units). The surveillance package included cross-sectional community surveys for microfilaremia (Mf) and circulating filarial antigenemia (CFA), school surveys for CFA and anti-filarial antibodies, and collection of Culex mosquitoes with gravid traps for detection of filarial DNA (molecular xenomonitoring, MX). Provisional target rates for interruption of LF transmission were community CFA <2%, antibody in school children <2%, and filarial DNA in mosquitoes <0.25%. Community Mf and CFA prevalence rates ranged from 0-0.9% and 0-3.4%, respectively. Infection rates were significantly higher in males and lower in people who denied prior treatment. Antibody rates in school children exceeded 2% in 10 study sites; the area that had the highest community and school CFA rates also had the highest school antibody rate (6.9%). Filarial DNA rates in mosquitoes exceeded 0.25% in 10 PHI areas.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Comprehensive surveillance is feasible for some national filariasis elimination programs. Low-level persistence of LF was present in all study sites; several sites failed to meet provisional endpoint criteria for LF elimination, and follow-up testing will be needed in these areas. TAS was not sensitive for detecting low-level persistence of filariasis in Sri Lanka. We recommend use of antibody and MX testing as tools to complement TAS for post-MDA surveillance.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rao</LastName>
<ForeName>Ramakrishna U</ForeName>
<Initials>RU</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nagodavithana</LastName>
<ForeName>Kumara C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo><Affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Samarasekera</LastName>
<ForeName>Sandhya D</ForeName>
<Initials>SD</Initials>
<AffiliationInfo><Affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wijegunawardana</LastName>
<ForeName>Asha D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo><Affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Premakumara</LastName>
<ForeName>Welmillage D Y</ForeName>
<Initials>WD</Initials>
<AffiliationInfo><Affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Perera</LastName>
<ForeName>Samudrika N</ForeName>
<Initials>SN</Initials>
<AffiliationInfo><Affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Settinayake</LastName>
<ForeName>Sunil</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Miller</LastName>
<ForeName>J Phillip</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weil</LastName>
<ForeName>Gary J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>AI065715</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Negl Trop Dis</MedlineTA>
<NlmUniqueID>101291488</NlmUniqueID>
<ISSNLinking>1935-2727</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018509">DNA, Helminth</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F4216019LN</RegistryNumber>
<NameOfSubstance UI="D015766">Albendazole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS Negl Trop Dis. 2014 Dec;(12):e3428</RefSource>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2013 Jan;107(1):15-22</RefSource>
<PMID Version="1">23222942</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 May;74(5):779-85</RefSource>
<PMID Version="1">16687680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2012 Jan;6(1):e1479</RefSource>
<PMID Version="1">22272369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 1991 Feb;85(1):123-9</RefSource>
<PMID Version="1">1888209</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2013 Sep 13;88(37):389-99</RefSource>
<PMID Version="1">24073461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Jpn J Exp Med. 1966 Dec;36(6):609-46</RefSource>
<PMID Version="1">4382197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2006 Mar 28;5:5</RefSource>
<PMID Version="1">16569234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Parasitol. 2007 Feb;23(2):78-82</RefSource>
<PMID Version="1">17174604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2013 Aug 22;369(8):745-53</RefSource>
<PMID Version="1">23964936</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1995 Nov;172(5):1414-7</RefSource>
<PMID Version="1">7594692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(12):e2584</RefSource>
<PMID Version="1">24340120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2014 Jan;90(1):89-95</RefSource>
<PMID Version="1">24189363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Today. 1997 Oct;13(10):401-4</RefSource>
<PMID Version="1">15275155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitol Int. 2014 Feb;63(1):87-93</RefSource>
<PMID Version="1">24060539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ecol Dis. 1983;2(4):309-19</RefSource>
<PMID Version="1">6152421</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 May;74(5):826-32</RefSource>
<PMID Version="1">16687688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource>
<PMID Version="1">16564361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Trop Med Parasitol. 2007 Jun;101(4):335-41</RefSource>
<PMID Version="1">17524248</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitology. 2000;121 Suppl:S147-60</RefSource>
<PMID Version="1">11386686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2011 Sep;120 Suppl 1:S19-22</RefSource>
<PMID Version="1">20430004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Filaria J. 2007 Nov 15;6:11</RefSource>
<PMID Version="1">18005398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(10):e2508</RefSource>
<PMID Version="1">24205421</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003465" MajorTopicYN="N">Culex</DescriptorName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018509" MajorTopicYN="N">DNA, Helminth</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007303" MajorTopicYN="N">Insect Vectors</DescriptorName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008842" MajorTopicYN="N">Microfilariae</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013188" MajorTopicYN="N">Sri Lanka</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4230885</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>04</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>09</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>5</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25393404</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pntd.0003281</ArticleId>
<ArticleId IdType="pii">PNTD-D-14-00651</ArticleId>
<ArticleId IdType="pmc">PMC4230885</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Sri Lanka</li>
<li>États-Unis</li>
</country>
<region><li>Missouri (État)</li>
</region>
<settlement><li>Saint-Louis (Missouri)</li>
</settlement>
<orgName><li>École de médecine (Université Washington de Saint-Louis)</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Missouri (État)"><name sortKey="Rao, Ramakrishna U" sort="Rao, Ramakrishna U" uniqKey="Rao R" first="Ramakrishna U" last="Rao">Ramakrishna U. Rao</name>
</region>
<name sortKey="Miller, J Phillip" sort="Miller, J Phillip" uniqKey="Miller J" first="J Phillip" last="Miller">J Phillip Miller</name>
<name sortKey="Weil, Gary J" sort="Weil, Gary J" uniqKey="Weil G" first="Gary J" last="Weil">Gary J. Weil</name>
</country>
<country name="Sri Lanka"><noRegion><name sortKey="Nagodavithana, Kumara C" sort="Nagodavithana, Kumara C" uniqKey="Nagodavithana K" first="Kumara C" last="Nagodavithana">Kumara C. Nagodavithana</name>
</noRegion>
<name sortKey="Perera, Samudrika N" sort="Perera, Samudrika N" uniqKey="Perera S" first="Samudrika N" last="Perera">Samudrika N. Perera</name>
<name sortKey="Premakumara, Welmillage D Y" sort="Premakumara, Welmillage D Y" uniqKey="Premakumara W" first="Welmillage D Y" last="Premakumara">Welmillage D Y. Premakumara</name>
<name sortKey="Samarasekera, Sandhya D" sort="Samarasekera, Sandhya D" uniqKey="Samarasekera S" first="Sandhya D" last="Samarasekera">Sandhya D. Samarasekera</name>
<name sortKey="Settinayake, Sunil" sort="Settinayake, Sunil" uniqKey="Settinayake S" first="Sunil" last="Settinayake">Sunil Settinayake</name>
<name sortKey="Wijegunawardana, Asha D" sort="Wijegunawardana, Asha D" uniqKey="Wijegunawardana A" first="Asha D" last="Wijegunawardana">Asha D. Wijegunawardana</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001709 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001709 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:25393404
   |texte=   A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:25393404" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki